Crossmark

Is Aspirin Loading Before Primary Percutaneous Coronary Intervention for Patients with ST-Elevation Myocardial Infarction Necessary?

Published Online: 2022-01-20

Published Print: 2022-12

Authors

Asanuma, Hiroshi

Kitakaze, Masafumi https://orcid.org/0000-0001-5157-4213
License Information

Text and Data Mining valid from 2022-01-20

Version of Record valid from 2022-01-20
More Information

Article History

Accepted: 8 January 2022

First Online: 20 January 2022

Declarations

:

: HA have nothing to disclose. MK reports grants from Japanese government, grants from Japan Heart Foundation, grants from Japan Agency for Medical Research and Development, personal fees from Daiichi-Sankyo, personal fees from Pfizer, grants and personal fees from Ono, personal fees from Bayer, grants and personal fees from Novartis, grants and personal fees from Boehringer, grants and personal fees from Tanabe-Mitsubishi, personal fees from Japan Medical Data Center, grants and personal fees from Takeda, and grants and personal fees from AstraZeneca, outside the submitted work.

Free to read: This content has been made available to all.

Document is current